Risks by outcome in different follow-up time frames after SVT
| . | Risks, % (95% CI)* . | ||||
|---|---|---|---|---|---|
| Outcome . | 0-10 y . | 0-3 mo . | >3 mo-1 y . | >1-5 y . | 5-10 y . |
| VTE | 13.82 (13.12-14.53) | 3.35 (3.02-3.70) | 2.35 (2.07-2.66) | 5.18 (4.72-5.66) | 5.09 (4.52-5.70) |
| Unprovoked VTE | 10.03 (9.42-10.66) | 2.02 (1.76-2.29) | 1.55 (1.33-1.81) | 3.93 (3.53-4.36) | 4.14 (3.63-4.70) |
| Provoked VTE | 4.00 (3.61-4.41) | 1.34 (1.14-1.57) | 0.80 (0.64-0.99) | 1.27 (1.05-1.53) | 0.97 (0.74-1.26) |
| DVT | 10.26 (9.65-10.89) | 2.47 (2.19-2.77) | 1.82 (1.58-2.10) | 3.74 (3.35-4.15) | 3.68 (3.20-4.20) |
| PE | 3.58 (3.21-3.97) | 0.88 (0.72-1.07) | 0.50 (0.38-0.65) | 1.35 (1.13-1.61) | 1.24 (0.98-1.56) |
| AMI | 4.49 (4.06-4.94) | 0.19 (0.12-0.29) | 0.55(0.42-0.71) | 1.96 (1.69-2.27) | 2.48 (2.10-2.91) |
| Ischemic stroke | 5.21 (4.74-5.70) | 0.28 (0.20-0.40) | 0.46 (0.35-0.61) | 2.09 (1.81-2.41) | 3.24 (2.80-3.73) |
| Death | 35.00 (33.97-36.04) | 2.65 (2.36-2.96) | 4.75 (4.35-5.17) | 13.56 (12.85-14.28) | 18.91 (17.91-19.94) |
| . | Risks, % (95% CI)* . | ||||
|---|---|---|---|---|---|
| Outcome . | 0-10 y . | 0-3 mo . | >3 mo-1 y . | >1-5 y . | 5-10 y . |
| VTE | 13.82 (13.12-14.53) | 3.35 (3.02-3.70) | 2.35 (2.07-2.66) | 5.18 (4.72-5.66) | 5.09 (4.52-5.70) |
| Unprovoked VTE | 10.03 (9.42-10.66) | 2.02 (1.76-2.29) | 1.55 (1.33-1.81) | 3.93 (3.53-4.36) | 4.14 (3.63-4.70) |
| Provoked VTE | 4.00 (3.61-4.41) | 1.34 (1.14-1.57) | 0.80 (0.64-0.99) | 1.27 (1.05-1.53) | 0.97 (0.74-1.26) |
| DVT | 10.26 (9.65-10.89) | 2.47 (2.19-2.77) | 1.82 (1.58-2.10) | 3.74 (3.35-4.15) | 3.68 (3.20-4.20) |
| PE | 3.58 (3.21-3.97) | 0.88 (0.72-1.07) | 0.50 (0.38-0.65) | 1.35 (1.13-1.61) | 1.24 (0.98-1.56) |
| AMI | 4.49 (4.06-4.94) | 0.19 (0.12-0.29) | 0.55(0.42-0.71) | 1.96 (1.69-2.27) | 2.48 (2.10-2.91) |
| Ischemic stroke | 5.21 (4.74-5.70) | 0.28 (0.20-0.40) | 0.46 (0.35-0.61) | 2.09 (1.81-2.41) | 3.24 (2.80-3.73) |
| Death | 35.00 (33.97-36.04) | 2.65 (2.36-2.96) | 4.75 (4.35-5.17) | 13.56 (12.85-14.28) | 18.91 (17.91-19.94) |
Cumulative incidences estimated treating death as a competing risk.